
Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover study
Keywords: β2-agonist; Cardiovascular; Safety; COPD; BDP; beclometasone dipropionate; DBP; diastolic blood pressure; DPI; dry powder inhaler; FDC; fixed-dose combination; FF; formoterol fumarate; PD; pharmacodynamic; pMDI; pressurised metered-dose inhaler; QTcF; QT